More Articles


Meet AI, The Doctor’s New Best Friend

Adam Chapman, (Dec 14, 2017)

AI insights will transform the HCPs practice in more ways than one, says Teva SVP Markus Leyck Dieken

Four Reasons Why Pharma Struggles To Engage HCPs Online (And How To Change That)

Danielle Barron, (Dec 8, 2017)

Pharma is failing to reach one of its critical customers in the online space, says Sanofi VP, Bozidar Jovicevic
Patients and Medical

Latin America: The Growing Pains Of Patient-Centricity

Adam Hill, (Dec 6, 2017)

US and European markets are steering the ship on patient-centricity. But where is Latin America in this space?
Access and Evidence

Shifting Gears

Adam Hill, (Nov 30, 2017)

McLaren has been a fixture of the Formula One circuit for half a century, but the company is now applying the technology it uses to monitor drivers and racing cars to solve health challenges

Pharma’s Place in the Digital Space

Adam Chapman, (Nov 24, 2017)

Sanofi’s Chief Data Officer expounds the possibilities of digital and the role of the CDO in this burgeoning landscape
Access and Evidence

Artificial Intelligence: Friend Or Foe?

Adam Chapman, (Nov 23, 2017)

AI is fast becoming a reality. What does this mean for medical affairs?
Access and Evidence

Instant Feedback

Adam Chapman, (Nov 22, 2017)

Insights derived from “real-life” data are being billed as the next phase of pharma. But are payers convinced?
Access and Evidence

Can Blockchain Solve Pharma’s Trust Problem?

Tom Disley, (Nov 20, 2017)

The Economist calls it “the trust machine” but can blockchain rejuvenate pharma’s savaged public image?
Patients and Medical

Medical Meets Machine

Danielle Barron, (Nov 15, 2017)

Pharma needs to be at the intersection between technological innovation and medical insight
Access and Evidence

The Price Of Access

Lucy Fulford, (Nov 13, 2017)

With tight purse strings right across the world, innovative pricing schemes are a crucial step in delivering affordable healthcare